← Back to search

UPPSALA UNIVERSITET

UPPSALA, 752 37

Prime contracting experience

2 records from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Prime
Department of Health and Human Services
Food and Drug Administration
BAA FY26C1CP41: ROBUST CLINICAL ENDPOINT BIOEQUIVALENCE STUDIES USING MODEL INTEGRATED EVALUATION APPROACHES—$499,922Sep 16, 2026Sep 1, 2026 – Aug 31, 2028
Prime
Department of Health and Human Services
Food and Drug Administration
MODEL-INTEGRATED STRATEGIES FOR BIOEQUIVALENCE EVALUATION OF DRUGS WITH HIGH VARIABILITY AND/OR LONG HALF-LIFE—$527,318Sep 24, 2024Sep 26, 2022 – Mar 31, 2025

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

  • Department of Health and Human ServicesGov-sourced

Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.

UPPSALA UNIVERSITET – Uppsala | UEI KTRDK57SR316 | FedSub